Abstract
P. Californicum (Papaveraceae), fire poppy, is traditionally used against pain. The seed pods were found to contain glycosides of 14-methylnormorphine and papaverine. The major alkaloid, ignimorphinan C67H80O19N2, is a mixture of sterol glycoside dimers of 14-methylnormorphine and papaverine. The second most abundant alkaloid, ignipapaverine C44H55O10N, is a sterol glycoside of papaverine. A possible glycoside of 2-methoxy-7-hydroxy-6-Omethyl- 7,8-dihydronormorphine-14-carbinol was found. Other compounds found were myricetin, malvidin-3-Oglucuronide and kaempferol acetate.
Keywords: P. Californicum, papaveraceae, fire poppy, alkaloid, 14-methylnormorphine, papaverine, Ignimorphinan, Ignipapaverine, opioids, sterol
The Natural Products Journal
Title: Opioid Alkaloids in Fire Poppies, Papaver Californicum
Volume: 2 Issue: 1
Author(s): James David Adams, Shin-Yu Lee, Julie Eunwoo Kim, Jirair Petrosyan, Mona Shahgholi and Roger Clemens
Affiliation:
Keywords: P. Californicum, papaveraceae, fire poppy, alkaloid, 14-methylnormorphine, papaverine, Ignimorphinan, Ignipapaverine, opioids, sterol
Abstract: P. Californicum (Papaveraceae), fire poppy, is traditionally used against pain. The seed pods were found to contain glycosides of 14-methylnormorphine and papaverine. The major alkaloid, ignimorphinan C67H80O19N2, is a mixture of sterol glycoside dimers of 14-methylnormorphine and papaverine. The second most abundant alkaloid, ignipapaverine C44H55O10N, is a sterol glycoside of papaverine. A possible glycoside of 2-methoxy-7-hydroxy-6-Omethyl- 7,8-dihydronormorphine-14-carbinol was found. Other compounds found were myricetin, malvidin-3-Oglucuronide and kaempferol acetate.
Export Options
About this article
Cite this article as:
David Adams James, Lee Shin-Yu, Eunwoo Kim Julie, Petrosyan Jirair, Shahgholi Mona and Clemens Roger, Opioid Alkaloids in Fire Poppies, Papaver Californicum, The Natural Products Journal 2012; 2 (1) . https://dx.doi.org/10.2174/2210315511202010031
DOI https://dx.doi.org/10.2174/2210315511202010031 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phospholipase A2 Inhibitors as Potential Anti-Inflammatory Agents
Current Pharmaceutical Design On the Involvement of H2S in Nitroso Signaling and Other Mechanisms of H2S Action
Current Pharmaceutical Biotechnology Profiling the Shear Stress of Atherosclerosis; A Genomic View
Current Genomics Renin-Angiotensin System Block and Atrial Fibrillation
Current Medicinal Chemistry The Adenosine A2b Receptor: Its Role in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
Current Vascular Pharmacology Pharmacogenetics of Antihypertensive Therapies: Can this be Applied in the Clinic?
Current Pharmacogenomics and Personalized Medicine Human Ether-a-Go-Go-Related Gene Channel Blockers and its Structural Analysis for Drug Design
Current Drug Targets Editorial[Hot Topic:Stem Cell Therapy for Cardiovascular Diseases:Are We Still at the Beginning of A Long Road?(Guest Editor:Lino M Goncalves)
Cardiovascular & Hematological Disorders-Drug Targets Patent Selections:
Recent Patents on Biomarkers Regulation of Intracellular Cardiomyocyte Calcium Stores by Peptides: A New Approach to Cardiac Protection
Current Medicinal Chemistry Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design Pharmacological Therapy in Children with Atrioventricular Reentry: Which Drug?
Current Pharmaceutical Design Hypoglycemia and Cardiac Arrhythmia; Mechanisms, Evidence Base a nd Current Recommendations
Current Diabetes Reviews Skeletal Muscle Derived Stem Cells for Myocardial Repair
Recent Patents on Cardiovascular Drug Discovery Efficacy and Complications of Subcutaneous <i>versus</i> Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
Current Cardiology Reviews Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Cell Sheet Technology for Heart Failure
Current Pharmaceutical Biotechnology Adenosine A<sub>3</sub> Receptor: A promising therapeutic target in cardiovascular disease
Current Cardiology Reviews